References
- Holl‐Wieden A., Klink T., Klink J., Warmuth‐Metz M., Girschick H. J. Linear scleroderma ‘en coup de sabre’ associated with cerebral and ocular vasculitis. Scand J Rheumatol 2006; 35: 402–4
- Archambault L., Fromm N. K. Progressive facial hemiatrophy: report of three cases. Arch Neurol Psychiatry 1932; 54: 75–9
- Wolfe M., Verity M. Neurological complications of progressive facial hemiatrophy. J Neurol Neurosurg Psychiatry 1974; 37: 997–1004
- Scibold J. R. Scleroderma. Textbook of rheumatology, W. N Kelley, E. D Jr Harris, S Ruddy, C. B Sledge. WB Saunders, Philadelphia 1989; 1215–44
- Garcia‐de la Torre I., Castello‐Sendra J., Esgleyes‐Ribot T., Martinez‐Bonilla G., Guerrerosantos J., Fritzler M. J. Autoantibodies in Parry–Romberg syndrome: a serologic study of 14 patients. J Rheumatol 1995; 22: 73–7
- Miedziak A. I., Stefanyszyn M., Flanagan J., Eagle R. C. Parry–Romberg syndrome associated with intracranial vascular manifestations. Arch Ophthalmol 1998; 116: 1235–7
- Aynaci F. M., Sen Y., Erdol H., Ahmetoglu A., Elmas R. Parry–Romberg syndrome associated with Adie's pupil and radiologic findings. Pediatr Neurol 2001; 25: 416–18
- Muchnick R. S., Aston S. J., Rees T. D. Ocular manifestations and treatment of hemifacial atrophy. Am J Ophthalmol 1979; 88: 889–7
- Lehman T. J. A. The Parry Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre. Mistaken diagnosis or overlapping conditions?. J Rheumatol 1992; 19: 844–5
- Stone J., Franks A. J., Guthrie J. A., Johnson M. H. Scleroderma ‘en coup de sabre’: pathological evidence of intracerebral inflammation. J Neurol Neurosurg Psychiatry 2001; 70: 382–5
- Korkmaz C., Adapinar B., Uysal S. Beneficial effect of immunosuppressive drugs on Parry–Romberg syndrome: a case report and review of the literature. South Med J 2005; 98: 939–41